Literature DB >> 8079988

Maternally inherited hypertrophic cardiomyopathy due to a novel T-to-C transition at nucleotide 9997 in the mitochondrial tRNA(glycine) gene.

F Merante1, I Tein, L Benson, B H Robinson.   

Abstract

We report a unique heteroplasmic T-to-C transition at nucleotide 9997 in the mitochondrial tRNA(glycine) gene in a multiplex family who manifested nonobstructive cardiomyopathy. The degree of mtDNA heteroplasmy generally correlated with the severity of the symptoms. This T-to-C transition disrupts hydrogen bonding in the region adjacent to the acceptor stem of the tRNA molecule. The thymine residue at position 9997 is highly conserved in mammals, as well as in various vertebrates and invertebrates. A PCR diagnostic test for the presence of the 9997 T-to-C transition revealed that the base change was always present in high proportion in affected family members, not present in unaffected family members, and never present in control subjects from various ethnic groups (25 groups sampled, 42 individuals), thus ruling out the possibility that this change represents a polymorphic variant in the general population. The degree of heteroplasmy in lymphoblast cultures also correlated with the level of enzyme activity present for cytochrome c oxidase (complex IV) and succinate cytochrome c oxidoreductase (complexes II and III). The absence of previously reported mtDNA mutations associated with hypertrophic cardiomyopathy was verified by both PCR diagnostic procedures and sequence analysis. All mitochondrial tRNA genes, as well as genes encoding ATPase subunits 6 and 8, were sequenced and found not to possess base changes consistent with the clinical profile. More detailed biochemical and molecular biological investigations are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8079988      PMCID: PMC1918404     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  45 in total

1.  Normal variants of human mitochondrial DNA and translation products: the building of a reference data base.

Authors:  S Marzuki; A S Noer; P Lertrit; D Thyagarajan; R Kapsa; P Utthanaphol; E Byrne
Journal:  Hum Genet       Date:  1991-12       Impact factor: 4.132

2.  Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy.

Authors:  H Watkins; A Rosenzweig; D S Hwang; T Levi; W McKenna; C E Seidman; J G Seidman
Journal:  N Engl J Med       Date:  1992-04-23       Impact factor: 91.245

3.  Heteroplasmic mtDNA mutation (T----G) at 8993 can cause Leigh disease when the percentage of abnormal mtDNA is high.

Authors:  Y Tatuch; J Christodoulou; A Feigenbaum; J T Clarke; J Wherret; C Smith; N Rudd; R Petrova-Benedict; B H Robinson
Journal:  Am J Hum Genet       Date:  1992-04       Impact factor: 11.025

4.  Patients with idiopathic cardiomyopathy belong to the same mitochondrial DNA gene family of Parkinson's disease and mitochondrial encephalomyopathy.

Authors:  T Ozawa; M Tanaka; S Sugiyama; H Ino; K Ohno; K Hattori; T Ohbayashi; T Ito; H Deguchi; K Kawamura
Journal:  Biochem Biophys Res Commun       Date:  1991-05-31       Impact factor: 3.575

5.  Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNA(Leu)(UUR).

Authors:  M Zeviani; C Gellera; C Antozzi; M Rimoldi; L Morandi; F Villani; V Tiranti; S DiDonato
Journal:  Lancet       Date:  1991-07-20       Impact factor: 79.321

6.  A mitochondrial tRNA anticodon swap associated with a muscle disease.

Authors:  C T Moraes; F Ciacci; E Bonilla; V Ionasescu; E A Schon; S DiMauro
Journal:  Nat Genet       Date:  1993-07       Impact factor: 38.330

7.  A biochemically distinct form of cytochrome oxidase (COX) deficiency in the Saguenay-Lac-Saint-Jean region of Quebec.

Authors:  F Merante; R Petrova-Benedict; N MacKay; G Mitchell; M Lambert; C Morin; M De Braekeleer; R Laframboise; R Gagné; B H Robinson
Journal:  Am J Hum Genet       Date:  1993-08       Impact factor: 11.025

8.  Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11.

Authors:  L Carrier; C Hengstenberg; J S Beckmann; P Guicheney; C Dufour; J Bercovici; E Dausse; I Berebbi-Bertrand; C Wisnewsky; D Pulvenis
Journal:  Nat Genet       Date:  1993-07       Impact factor: 38.330

9.  A tRNA(Lys) mutation in the mtDNA is the causal genetic lesion underlying myoclonic epilepsy and ragged-red fiber (MERRF) syndrome.

Authors:  A S Noer; H Sudoyo; P Lertrit; D Thyagarajan; P Utthanaphol; R Kapsa; E Byrne; S Marzuki
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

10.  The mitochondrial tRNA(Leu(UUR)) mutation in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS): genetic, biochemical, and morphological correlations in skeletal muscle.

Authors:  C T Moraes; E Ricci; E Bonilla; S DiMauro; E A Schon
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

View more
  26 in total

Review 1.  Clinical mitochondrial genetics.

Authors:  P F Chinnery; N Howell; R M Andrews; D M Turnbull
Journal:  J Med Genet       Date:  1999-06       Impact factor: 6.318

2.  Cardiac mitochondrial dysfunction and DNA depletion in children with hypertrophic cardiomyopathy.

Authors:  J Marin-Garcia; R Ananthakrishnan; M J Goldenthal; J J Filiano; A Perez-Atayde
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

Review 3.  Multisystem manifestations of mitochondrial disorders.

Authors:  Stefano Di Donato
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

Review 4.  Mitochondrial DNA mutations and pathogenesis.

Authors:  E A Schon; E Bonilla; S DiMauro
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

5.  A new mtDNA mutation showing accumulation with time and restriction to skeletal muscle.

Authors:  K Weber; J N Wilson; L Taylor; E Brierley; M A Johnson; D M Turnbull; L A Bindoff
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

Review 6.  Myocardial energy depletion and dynamic systolic dysfunction in hypertrophic cardiomyopathy.

Authors:  Julian O M Ormerod; Michael P Frenneaux; Mark V Sherrid
Journal:  Nat Rev Cardiol       Date:  2016-07-14       Impact factor: 32.419

7.  Congenital encephalomyopathy and adult-onset myopathy and diabetes mellitus: different phenotypic associations of a new heteroplasmic mtDNA tRNA glutamic acid mutation.

Authors:  M G Hanna; I Nelson; M G Sweeney; J M Cooper; P J Watkins; J A Morgan-Hughes; A E Harding
Journal:  Am J Hum Genet       Date:  1995-05       Impact factor: 11.025

Review 8.  Electron transport chain defects in heart failure.

Authors:  Jordi Casademont; Oscar Miró
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

9.  Decreased contractility due to energy deprivation in a transgenic rat model of hypertrophic cardiomyopathy.

Authors:  Mark Luedde; Ulrich Flögel; Maike Knorr; Christina Grundt; Hans-Joerg Hippe; Benedikt Brors; Derk Frank; Uta Haselmann; Claude Antony; Mirko Voelkers; Juergen Schrader; Patrick Most; Bjoern Lemmer; Hugo A Katus; Norbert Frey
Journal:  J Mol Med (Berl)       Date:  2009-02-03       Impact factor: 4.599

10.  A novel mitochondrial tRNA(Val) T1658C mutation identified in a CPEO family.

Authors:  Naihong Yan; Shuping Cai; Bo Guo; Yi Mou; Jing Zhu; Jun Chen; Ting Zhang; Ronghua Li; Xuyang Liu
Journal:  Mol Vis       Date:  2010-08-25       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.